Status:
NOT_YET_RECRUITING
Anxiety is One of the Most Frequent Disorders During the Perinatal Stage Which is Associated with Adverse Health Effects for Women and Their Babies. This Study Will Be to Evaluate the Effectiveness of a Telematic Cognitive-behavioral Preventive Intervention to Manage Anxiety During Pregnancy.
Lead Sponsor:
University of Santiago de Compostela
Conditions:
Anxiety Disorder (Panic Disorder or GAD)
Anxiety Symptoms
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Anxiety is one of the most frequent disorders during the perinatal stage which is associated with adverse health effects for women and their babies. In spite of this, preventive interventions during t...
Detailed Description
Anxiety is one of the most frequent disorders during the perinatal stage. Its prevalence is between 15% and 23% during the pregnancy, and between 3,7% and 15,0% during postpartum. In Spain, the preval...
Eligibility Criteria
Inclusion
- Women over 18 years of age living in the Region of Galicia (Spain)
- Pregnant with a gestational age ≤ 16
- Understand and speak Spanish fluently
- Informed consent to participate in the study
- Accessibility to the internet and a digital device ( computer, tablet or smartphone)
Exclusion
- High-risk pregnancy or twins
- Being pharmacological treatment for anxiety and/or depression
- Not giving their consent
Key Trial Info
Start Date :
December 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06609291
Start Date
December 1 2024
End Date
December 1 2025
Last Update
September 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Facultade de Psicoloxía, Universidade de Santiago de Compostela
Santiago de Compostela, A Coruña, Spain, 15782